BEAN1 Gene Spinocerebellar ataxia type 31 autosomal dominant Genetic Test
Welcome to DNA Labs UAE, your trusted genetic testing lab in UAE. We offer the BEAN1 Gene Spinocerebellar ataxia type 31 autosomal dominant Genetic Test at a cost of AED 4400.0.
Test Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Neurological Disorders
- Doctor: Neurologist
- Test Department: Genetics
Pre Test Information
Before undergoing the BEAN1 Gene Spinocerebellar ataxia type 31 autosomal dominant Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with BEAN1 Gene Spinocerebellar ataxia type 31, autosomal dominant.
Test Details
The BEAN1 gene is associated with a specific type of spinocerebellar ataxia called spinocerebellar ataxia type 31 (SCA31). This genetic condition is inherited in an autosomal dominant manner, meaning that an affected individual has a 50% chance of passing the gene mutation to each of their children.
NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes or even the entire genome. In the case of SCA31, NGS genetic testing can be used to identify mutations in the BEAN1 gene, which can help confirm a diagnosis of SCA31 in individuals with symptoms suggestive of the condition.
The genetic test involves obtaining a sample of the individual’s DNA, typically through a blood or saliva sample. The DNA is then sequenced using NGS technology to identify any variations or mutations in the BEAN1 gene. If a mutation is detected, it can provide a definitive diagnosis of SCA31.
NGS genetic testing for SCA31 can be useful for individuals who have symptoms of spinocerebellar ataxia and want to confirm a diagnosis, as well as for family members of individuals with SCA31 who may be at risk of inheriting the gene mutation. It can also be used for genetic counseling purposes to provide information about the likelihood of passing on the gene mutation to future generations.
| Test Name | BEAN1 Gene Spinocerebellar ataxia type 31 autosomal dominant Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for BEAN1 Gene Spinocerebellar ataxia type 31, autosomal dominant NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with BEAN1 Gene Spinocerebellar ataxia type 31, autosomal dominant |
| Test Details |
The BEAN1 gene is associated with a specific type of spinocerebellar ataxia called spinocerebellar ataxia type 31 (SCA31). This genetic condition is inherited in an autosomal dominant manner, meaning that an affected individual has a 50% chance of passing the gene mutation to each of their children. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes or even the entire genome. In the case of SCA31, NGS genetic testing can be used to identify mutations in the BEAN1 gene, which can help confirm a diagnosis of SCA31 in individuals with symptoms suggestive of the condition. The genetic test involves obtaining a sample of the individual’s DNA, typically through a blood or saliva sample. The DNA is then sequenced using NGS technology to identify any variations or mutations in the BEAN1 gene. If a mutation is detected, it can provide a definitive diagnosis of SCA31. NGS genetic testing for SCA31 can be useful for individuals who have symptoms of spinocerebellar ataxia and want to confirm a diagnosis, as well as for family members of individuals with SCA31 who may be at risk of inheriting the gene mutation. It can also be used for genetic counseling purposes to provide information about the likelihood of passing on the gene mutation to future generations. |
